Northern Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $193M | Buy |
|
|||||
2025
Q1 | $205M | Sell |
|
|||||
2024
Q4 | $237M | Buy |
|
|||||
2024
Q3 | $262M | Sell |
|
|||||
2024
Q2 | $331M | Buy |
|
|||||
2024
Q1 | $299M | Sell |
|
|||||
2023
Q4 | $387M | Sell |
|
|||||
2023
Q3 | $422M | Buy |
|
|||||
2023
Q2 | $455M | Sell |
|
|||||
2023
Q1 | $465M | Sell |
|
|||||
2022
Q4 | $463M | Sell |
|
|||||
2022
Q3 | $450M | Sell |
|
|||||
2022
Q2 | $349M | Buy |
|
|||||
2022
Q1 | $355M | Sell |
|
|||||
2021
Q4 | $406M | Sell |
|
|||||
2021
Q3 | $498M | Sell |
|
|||||
2021
Q2 | $716M | Sell |
|
|||||
2021
Q1 | $593M | Sell |
|
|||||
2020
Q4 | $539M | Sell |
|
|||||
2020
Q3 | $676M | Sell |
|
|||||
2020
Q2 | $652M | Sell |
|
|||||
2020
Q1 | $782M | Sell |
|
|||||
2019
Q4 | $739M | Sell |
|
|||||
2019
Q3 | $650M | Sell |
|
|||||
2019
Q2 | $674M | Sell |
|
|||||
2019
Q1 | $685M | Sell |
|
|||||
2018
Q4 | $875M | Buy |
|
|||||
2018
Q3 | $980M | Sell |
|
|||||
2018
Q2 | $840M | Buy |
|
|||||
2018
Q1 | $787M | Sell |
|
|||||
2017
Q4 | $949M | Sell |
|
|||||
2017
Q3 | $948M | Buy |
|
|||||
2017
Q2 | $819M | Buy |
|
|||||
2017
Q1 | $764M | Sell |
|
|||||
2016
Q4 | $792M | Sell |
|
|||||
2016
Q3 | $932M | Buy |
|
|||||
2016
Q2 | $717M | Sell |
|
|||||
2016
Q1 | $788M | Sell |
|
|||||
2015
Q4 | $927M | Sell |
|
|||||
2015
Q3 | $925M | Buy |
|
|||||
2015
Q2 | $1.25B | Sell |
|
|||||
2015
Q1 | $1.32B | Sell |
|
|||||
2014
Q4 | $1.07B | Sell |
|
|||||
2014
Q3 | $1.07B | Buy |
|
|||||
2014
Q2 | $993M | Sell |
|
|||||
2014
Q1 | $1.01B | Buy |
|
|||||
2013
Q4 | $895M | Sell |
|
|||||
2013
Q3 | $774M | Sell |
|
|||||
2013
Q2 | $720M | Buy |
|